Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
RedHill Biopharma ADR | RDHL | Mar 14, 2025 | 2.56 | -1.54 |
Redwire | RDW | Mar 14, 2025 | 10.60 | +13.01 |
Redwood Trust | RWT-A | Mar 14, 2025 | 25.36 | +0.71 |
Redwood Trust | RWT | Mar 14, 2025 | 6.39 | +3.57 |
REE Automotive A | REE | Mar 14, 2025 | 6.43 | +8.43 |
Regal Rexnord | RRX | Mar 14, 2025 | 116.72 | +1.59 |
Regency Centers | REG | Mar 14, 2025 | 71.07 | +0.97 |
Regency Centers A Pref | REGCP | Mar 14, 2025 | 23.71 | +0.55 |
Regency Centers B Pref | REGCO | Mar 14, 2025 | 22.44 | +0.54 |
Regeneron Pharmaceuticals | REGN | Mar 14, 2025 | 666.87 | -2.02 |
REGENXBIO | RGNX | Mar 14, 2025 | 6.72 | +2.60 |
Regional Management | RM | Mar 14, 2025 | 29.79 | +2.80 |
Regions Financial | RF | Mar 14, 2025 | 21.43 | +2.83 |
Regions Financial C Pref | RF-C | Mar 14, 2025 | 23.78 | -0.17 |
Regions Financial E Pref | RF-E | Mar 14, 2025 | 17.71 | +0.74 |
Regions Finl New Dep Shs Repstg 1100th Perp Pfd Ser F | RF-F | Mar 14, 2025 | 25.48 | +0.04 |
Regis | RGS | Mar 14, 2025 | 18.29 | +4.34 |
Regulus Therapeutics | RGLS | Mar 14, 2025 | 1.48 | +7.25 |
Rein Therapeutics | RNTX | Mar 14, 2025 | 2.00 | 0.00 |
Reinsurance Group of America | RGA | Mar 14, 2025 | 191.50 | +2.95 |
REIT Index ETF Vanguard | VNQ | Mar 14, 2025 | 90.17 | +2.00 |
Reitar Logtech | RITR | Mar 14, 2025 | 3.29 | +7.87 |
Rekor Systems | REKR | Mar 14, 2025 | 1.09 | +6.86 |
Relay Therapeutics | RLAY | Mar 14, 2025 | 3.66 | +7.33 |
Reliance | RS | Mar 14, 2025 | 282.78 | +1.38 |
Reliance Global | RELI | Mar 14, 2025 | 1.28 | -1.54 |
Relmada Therapeutics | RLMD | Mar 14, 2025 | 0.29 | +7.69 |
RELX ADR | RELX | Mar 14, 2025 | 48.93 | +2.34 |
Remitly Global | RELY | Mar 14, 2025 | 19.90 | +0.66 |
Renaissance Ipo ETF | IPO | Mar 14, 2025 | 38.93 | +3.68 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.